Finland· FI-REL-REL9722
Infanrix-Polio+Hib
A diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus product containing corynebacterium diphtheriae toxoid, adsorbed + clostridium tetani toxoid, adsorbed + bordetella pertussis toxoid, adsorbed + bordetella pertussis filamentous haemagglutinin, adsorbed + 5 more, registered in Finland by GlaxoSmithKline Biologicals SA. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus is registered in 8 of 19 countries.
Countries holding a registration under ATC J07CA06 (diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus · ATC J07CA06
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Corynebacterium diphtheriae toxoid, adsorbed + Clostridium tetani toxoid, adsorbed + Bordetella pertussis toxoid, adsorbed + Bordetella pertussis filamentous haemagglutinin, adsorbed + 5 more
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Country
- Finland (FI)
- ATC code
- J07CA06
- ATC class
- Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07CA06
Diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus, as other registers publish it.
- PolandInfanrix - IPV + HibGlaxoSmithKline Biologicals S.A.
- SwitzerlandInfanrix DTPa-IPV+Hib
- SwitzerlandInfanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer InjektionssuspensionGlaxoSmithKline AG
- BelgiumInfanrix IPV + HibGlaxoSmithKline Biologicals
- SpainINFANRIX-IPV+HIB POLVO Y SUSPENSION PARA SUSPENSION INYECTABLEGlaxosmithkline S.A.
- DenmarkInfanrix-Polio+HibGlaxoSmithKline Pharma A/S
- FinlandPediacelSanofi Pasteur Europe
- CanadaPENTACELSANOFI PASTEUR LIMITED
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2d7c8d3-a238-48b3-b019-5c91f3939a3b GET /v1/drugs/d2d7c8d3-a238-48b3-b019-5c91f3939a3b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja suspensio, suspensiota varten",
"route": "Lihakseen",
"ddd_unit": null,
"strength": null,
"atc_label": "kurkkumätä-, Haemophilus influenzae tyyppi b -, hinkuyskä-, polio-, jäykkäkouristusrokote",
"ma_number": "13043",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL9722",
"authorised_at": "1999-03-29"
}See everything about diphtherie-haemophilus-influenzae b-pertussis-poliomyelitis-tetanus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.